Engineered Multivariate Metal-Organic Frameworks for Magnetic Resonance Molecular Imaging Signal Enhancement
Related Experiment Video
Updated: Oct 31, 2026

Optimizing Magnetic Force Microscopy Resolution and Sensitivity to Visualize Nanoscale Magnetic Domains
Published on: July 20, 2022
Zhen Wang1,2, Qingbin Zeng1,2, Chenlu Yuan1,2
1State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan430071, P. R. China.
Abstract:
Trapping Xe atoms within MOFs represents a promising strategy for hyperpolarized 129Xe MRI, owing to their structural tunability and ultrahigh porosity. Enhancing the entrapped 129Xe NMR signal is critical to overcoming current limitations of 129Xe MRI in biomedical applications. Although metal-centered doping has been explored to boost 129Xe signals, ligand-centered precise engineering to optimize the entrapped 129Xe NMR signal in MOFs remains largely underexplored. Herein, we present, for the first time, a ligand-based multivariate engineering approach to enhance the entrapped 129Xe NMR signal of water-stable CAU-1-derived MTV-MOFs. By finely tuning the molar ratio of -OH and -NH2 functionalized linkers, the pore microenvironment and Xe-framework interactions are continuously modulated. The MTV-MOF with the optimal ligand composition exhibits a remarkable 65-fold enhancement in 129Xe NMR signal compared to the single-component MOF. Furthermore, this material demonstrates excellent 129Xe MRI performance in living cells, highlighting its potential for biomedical imaging. This ligand-engineered multivariate approach establishes a versatile platform for tailoring Xe-host interactions in MOFs, offering a promising pathway to develop high-performance Xe molecular cages and expand the frontier of MOF-based molecular imaging technologies.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging

